GNMK
GenMark Diagnostics, Inc
GNMK
GNMK
Delisted
GNMK was delisted on the 21st of April, 2021.
77 hedge funds and large institutions have $380M invested in GenMark Diagnostics, Inc in 2016 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 30 increasing their positions, 23 reducing their positions, and 11 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
-9
Holders Change %
-10.47%
% of All Funds
2.06%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.03%
New
3
Increased
30
Reduced
23
Closed
11
Calls
$97K
Puts
$101K
Net Calls
-$4K
Net Calls Change
–
Top Buyers
| 1 |
NC
Northpointe Capital
Bloomfield Hills,
Michigan
|
+$4.44M |
| 2 |
Morgan Stanley
New York
|
+$4.39M |
| 3 |
CC
Casdin Capital
New York
|
+$3.61M |
| 4 |
CCM
Cadian Capital Management
New York
|
+$2.09M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$1.09M |
Top Sellers
| 1 |
PI
Putnam Investments
Boston,
Massachusetts
|
-$4.4M |
| 2 |
VAM
Visium Asset Management
New York
|
-$2.31M |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$2.09M |
| 4 |
GTC
Ghost Tree Capital
New York
|
-$1.58M |
| 5 |
Jennison Associates
New York
|
-$1.49M |
